Risk factor analysis of Histoplasma capsulatum fungemia

M A Assi1, M S Sandid, L M Baddour

  • 1Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. maassi@hotmail.com

Medical Mycology
|February 13, 2009
PubMed

Insights

Immunocompromised status and low peripheral leukocyte count (WBC) are key risk factors for Histoplasma capsulatum fungemia, a serious fungal infection. Identifying these factors aids in early detection and management of this condition.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Epidemiology

Background:

  • Histoplasma capsulatum fungemia is a severe manifestation of histoplasmosis.
  • Risk factors for developing H. capsulatum fungemia require further investigation for improved patient outcomes.

Purpose of the Study:

  • To identify independent risk factors associated with Histoplasma capsulatum fungemia.
  • To analyze patient data retrospectively to determine predictors of H. capsulatum fungemia.

Main Methods:

  • A retrospective case-control study was conducted involving 111 patients diagnosed with histoplasmosis.
  • Blood cultures were analyzed to identify cases of H. capsulatum fungemia (55 patients) versus controls (56 patients).
  • Univariate and multivariable analyses were performed to assess risk factors including immunocompromised status, leukocyte count, albumin levels, and Charlson score.

Main Results:

  • Immunocompromised status (Odds Ratio [OR] 2.4, P=0.043) and a peripheral leukocyte count (WBC) below 3000 cells/mm³ (OR 6.5, P=0.001) were significant independent risk factors for H. capsulatum fungemia.
  • Univariate analysis also identified low albumin and high Charlson scores as potential risk factors.
  • Age over 55 years was not found to be a significant risk factor.

Conclusions:

  • Immunocompromised status and a low peripheral leukocyte count (WBC < 3000 cells/mm³) are significant independent risk factors for H. capsulatum fungemia.
  • These findings highlight the importance of monitoring WBC counts in immunocompromised individuals at risk for histoplasmosis.
  • Early recognition of these risk factors can guide clinical management and potentially reduce the incidence of fungemia.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...